Status:

COMPLETED

Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Cardiac Health

Eligibility:

All Genders

18+ years

Brief Summary

The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in ...

Eligibility Criteria

Inclusion

  • Patient \> or = to 18 years of age
  • Registered patient at MSKCC
  • Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008-2011

Exclusion

  • Patient is unwilling to participate

Key Trial Info

Start Date :

November 8 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 18 2017

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT01474577

Start Date

November 8 2011

End Date

May 18 2017

Last Update

April 9 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Memorial Sloan-Kettering Cancer Center

New York, New York, United States, 10065

Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging | DecenTrialz